Quick Answer
Adicet Bio, Inc. reported Net Income Loss of -$116.80 million for the year ending 2025.
- Adicet Bio, Inc. showed an increase of +0.3% in Net Income Loss from 2024 to 2025.
- This data is from Adicet Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Adicet Bio, Inc.'s Net Income Loss has declined by 245.8%.
- Historical annual values: Fiscal year 2025: -$116.80 million | Fiscal year 2024: -$117.12 million | Fiscal year 2023: -$142.66 million | Fiscal year 2022: -$69.79 million | Fiscal year 2021: -$62.00 million | Fiscal year 2020: -$36.68 million | Fiscal year 2019: -$28.14 million | Fiscal year 2018: -$9.30 million | Fiscal year 2017: -$33.78 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: